Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity

Thrombosis Research

Volumn 129, Issue 2, 2012, Pages 197-203

  Boles, Jeremiah C ^a   Williams, Julie C ^a   Hollingsworth, Rachel M ^a   Wang, Jian Guo ^a   Glover, Sam L ^a   Owens III, A Phillip ^a   Barcel, David A ^b   Kasthuri, Raj S ^a   Key, Nigel S ^a   MacKman, Nigel ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Leukemia; Microparticle; Phosphatidylserine; Procoagulant activity; Thrombosis; Tissue factor

Indexed keywords

ANTHRACYCLINE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; LACTADHERIN; LIPOCORTIN 5; MESSENGER RNA; PHOSPHATIDYLSERINE; THROMBOPLASTIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTIC LEUKEMIA; PRIORITY JOURNAL; THROMBOSIS;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CELL LINE; CELL MEMBRANE; CELL-DERIVED MICROPARTICLES; HUMANS; LEUKEMIA, MYELOID; PHOSPHATIDYLSERINES; THROMBOPLASTIN;

EID: 84855879112     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.06.022     Document Type: Article

References (42)

1. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 23 Suppl 1 Jun 17 2003 I17 I21
2. J.W. Blom, J.P. Vanderschoot, M.J. Oostindier, S. Osanto, F.J. van der Meer, and F.R. Rosendaal Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 3 Mar 2006 529 535
3. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. OFallon, and L.J. Melton 3rd Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 6 Mar 27 2000 809 815 (Pubitemid 30165241)
4. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 6 Feb 9 2005 715 722 (Pubitemid 40216041)
5. A. Falanga, and M. Marchetti Venous thromboembolism in the hematologic malignancies J Clin Oncol 27 29 Oct 10 2009 4848 4857
6. J.M. Bennett, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, and H.R. Gralnick Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group Ann Intern Med 103 4 Oct 1985 620 625
7. H.F. Fernandez New trends in the standard of care for initial therapy of acute myeloid leukemia Hematol Am Soc Hematol Educ Program 2010 2010 56 61
8. T. Barbui, and A. Falanga Disseminated intravascular coagulation in acute leukemia Semin Thromb Hemost 27 6 Dec 2001 593 604 (Pubitemid 33152572)
9. M.E. Tesselaar, F.P. Romijn, I.K. Van Der Linden, F.A. Prins, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 3 Mar 2007 520 527 (Pubitemid 46680685)
10. R.S. Kasthuri, M.B. Taubman, and N. Mackman Role of tissue factor in cancer J Clin Oncol 27 29 Oct 10 2009 4834 4838
11. M.E. Tesselaar, F.P. Romijn, I.K. van der Linden, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity in cancer patients with and without thrombosis J Thromb Haemost 7 8 Aug 2009 1421 1423
12. G. Hron, M. Kollars, H. Weber, V. Sagaster, P. Quehenberger, and S. Eichinger Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer Thromb Haemost 97 1 Jan 2007 119 123 (Pubitemid 46242392)
13. A.A. Khorana, C.W. Francis, K.E. Menzies, J.G. Wang, O. Hyrien, and J. Hathcock Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer J Thromb Haemost 6 11 Nov 2008 1983 1985
14. N. Mackman The many faces of tissue factor J Thromb Haemost 7 Suppl. 1 Jul 2009 136 139
15. D.A. Manly, J. Boles, and N. Mackman Role of tissue factor in venous thrombosis Annu Rev Physiol Mar 17 73 2011 515 525
16. A.P. Owens 3rd, and N. Mackman Tissue factor and thrombosis: The clot starts here Thromb Haemost 104 3 Sep 2010 432 439
17. R. Pawlinski, and N. Mackman Cellular sources of tissue factor in endotoxemia and sepsis Thromb Res 125 Suppl. 1 Apr 2010 S70 S73
18. P.L. Giesen, U. Rauch, B. Bohrmann, D. Kling, M. Roque, and J.T. Fallon Blood-borne tissue factor: another view of thrombosis Proc Natl Acad Sci USA 96 5 Mar 2 1999 2311 2315 (Pubitemid 29117911)
19. H. Takahashi, N. Satoh, K. Wada, E. Takakuwa, Y. Seki, and A. Shibata Tissue factor in plasma of patients with disseminated intravascular coagulation Am J Hematol 46 4 Aug 1994 333 337 (Pubitemid 24243879)
20. H. Asakura, Y. Kamikubo, A. Goto, Y. Shiratori, M. Yamazaki, and H. Jokaji Role of tissue factor in disseminated intravascular coagulation Thromb Res 80 3 Nov 1 1995 217 224
21. R.R. Bach Tissue factor encryption Arterioscler Thromb Vasc Biol 26 3 Mar 2006 456 461
22. R.R. Bach, and C.F. Moldow Mechanism of tissue factor activation on HL-60 cells Blood 89 9 May 1 1997 3270 3276 (Pubitemid 27229812)
23. I. Del Conde, C.N. Shrimpton, P. Thiagarajan, and J.A. Lopez Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation Blood 106 5 Sep 1 2005 1604 1611 (Pubitemid 41208572)
24. V.M. Chen, J. Ahamed, H.H. Versteeg, M.C. Berndt, W. Ruf, and P.J. Hogg Evidence for activation of tissue factor by an allosteric disulfide bond Biochemistry 45 39 Oct 3 2006 12020 12028 (Pubitemid 44497827)
25. J.M. Freyssinet, and F. Toti Formation of procoagulant microparticles and properties Thromb Res 125 Suppl. 1 Apr 2010 S46 S48
26. O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, and F. Dignat-George Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26 12 Dec 2006 2594 2604
27. K. Misumi, H. Ogawa, H. Yasue, H. Soejima, H. Suefuji, and K. Nishiyama Comparison of plasma tissue factor levels in unstable and stable angina pectoris Am J Cardiol 81 1 Jan 1 1998 22 26 (Pubitemid 28046836)
28. O. Aras, A. Shet, R.R. Bach, J.L. Hysjulien, A. Slungaard, and R.P. Hebbel Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia Blood 103 12 Jun 15 2004 4545 4553 (Pubitemid 38745982)
29. D.A. Manly, J. Wang, S.L. Glover, R. Kasthuri, H.A. Liebman, and N.S. Key Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism Thromb Res 125 6 Jun 2010 511 512
30. J.I. Zwicker, H.A. Liebman, D. Neuberg, R. Lacroix, K.A. Bauer, and B.C. Furie Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin Cancer Res 15 22 Nov 15 2009 6830 6840
31. L. Ma, G. Francia, A. Viloria-Petit, D.J. Hicklin, J. du Manoir, and J. Rak In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy Cancer Res 65 12 Jun 15 2005 5365 5373 (Pubitemid 40827350)
32. L.L. Swystun, L.Y. Shin, S. Beaudin, and P.C. Liaw Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes J Thromb Haemost 7 4 Apr 2009 619 626
33. D. Lechner, M. Kollars, A. Gleiss, P.A. Kyrle, and A. Weltermann Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity J Thromb Haemost 5 12 Dec 2007 2445 2452 (Pubitemid 350154355)
34. Y. Fu, J. Zhou, H. Li, F. Cao, Y. Su, and S. Fan Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release Thromb Haemost 104 6 Dec 2010 1235 1241
35. J. Zhou, Y. Zheng, J. Shi, C. Lu, J. Hou, and H. Yu Daunorubicin induces procoagulant response through phosphatidylserine exposure in red blood cells Thromb Res 125 2 Feb 2010 178 183
36. J. Zhou, J. Shi, J. Hou, F. Cao, Y. Zhang, and J.T. Rasmussen Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia J Thromb Haemost 8 4 Apr 2010 773 782
37. R. Lacroix, S. Robert, P. Poncelet, R.S. Kasthuri, N.S. Key, and F. Dignat-George Standardization of platelet-derived microparticle enumeration by flow cytometry using calibrated beads: results of ISTH SSC collaborative workshop J Thromb Haemost 8 11 Nov 2010 2571 2574
38. C.A. Slapak, J.M. Lecerf, J.C. Daniel, and S.B. Levy Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts J Biol Chem 267 15 May 25 1992 10638 10644
39. J. Robert, P. Vrignaud, T. Nguyen-Ngoc, A. Iliadis, L. Mauriac, and P. Hurteloup Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer Cancer Treat Rep 69 6 Jun 1985 633 640 (Pubitemid 15031678)
40. V.H. Bramwell, D. Morris, D.S. Ernst, I. Hings, M. Blackstein, and P.M. Venner Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma Clin Cancer Res 8 2 Feb 2002 383 393 (Pubitemid 34193954)
41. H.F. Fernandez, Z. Sun, X. Yao, M.R. Litzow, S.M. Luger, and E.M. Paietta Anthracycline dose intensification in acute myeloid leukemia N Engl J Med 361 13 Sep 24 2009 1249 1259
42. J.J. Auwerda, Y. Yuana, S. Osanto, M.P. de Maat, P. Sonneveld, and R.M. Bertina Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma Thromb Haemost 105 1 Jan 3 2011 14 20